RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Not long until the AGM Good points Eoganacht, my thought is not unlike many here that as hospitals in both countries clear away the backlog of elective surgery we should see less patient strain/anxiety in our PH2 trial thus moving the CR rates higher. As CancerSlayer once said within this trial we have our own comparative groups in the undertreated and the optimized, will Dr. Sherri McFarland use this in her discussion? My point is again like many here that we should see increasing CR in each upcoming release of Newsletter updates.
My biggest hope is that Dr. Sherri McFarland attend the AGM one day after Theralase proves this isn't a pipe dream, if she does attend she will be treated like a celebrity.
Eoganacht wrote
Dr. McFarland will likely be revealing to the rest of the world the same data we TLT-heads have been going over for months, as we try to squeeze a little extra insight from the bare facts revealed in the news releases. The difference is that Dr. McFarland is in a better position to better understand the significance of some of the factual tidbits that may have gone over our heads. fredgoodwinson wrote: That`s understood - although some of her past published comments have suggested greater operational insight than mine (for example!).